Table 9.
Item | CTL1 | CTC1 | FSE1 | SEM | P-value |
---|---|---|---|---|---|
C12:0 | 0.04 | 0.04 | 0.03 | 0.01 | 0.82 |
C14:0 | 0.49 | 0.49 | 0.49 | 0.01 | 0.79 |
C14:1 | 0.10 | 0.09 | 0.09 | 0.01 | 0.96 |
C15:0 | 0.08 | 0.08 | 0.08 | 0.01 | 0.79 |
C16:0 | 20.99 | 20.62 | 20.68 | 0.48 | 0.85 |
C16:1 | 3.74 | 3.58 | 3.64 | 0.42 | 0.97 |
C17:0 | 0.14 | 0.14 | 0.13 | 0.01 | 1.00 |
C18:0 | 6.91 | 7.18 | 7.00 | 0.40 | 0.93 |
C18:1n9c | 32.86 | 31.79 | 32.08 | 1.13 | 0.67 |
C18:2n6c | 29.06 | 29.50 | 29.49 | 0.91 | 0.85 |
C18:3n3 | 2.42 | 2.47 | 2.62 | 0.09 | 0.21 |
C20:0 | 0.11 | 0.11 | 0.11 | 0.01 | 0.71 |
C20:1 | 0.28 | 0.28 | 0.28 | 0.01 | 0.64 |
C21:0 | 0.28 | 0.35 | 0.33 | 0.07 | 0.68 |
C20:3n6 | 0.33 | 0.39 | 0.37 | 0.06 | 0.64 |
C20:4n6 | 1.21 | 1.62 | 1.43 | 0.43 | 0.81 |
C20:3n3 | 0.03 | 0.04 | 0.04 | 0.01 | 0.32 |
C20:5n3 | 0.20 | 0.22 | 0.22 | 0.02 | 0.68 |
C22:0 | 0.06 | 0.06 | 0.06 | 0.01 | 0.83 |
C24:0 | 0.35 | 0.48 | 0.43 | 0.13 | 0.74 |
C22:6n3 | 0.31 | 0.40 | 0.34 | 0.10 | 0.78 |
C24:1 | 0.04 | 0.06 | 0.06 | 0.02 | 0.68 |
SFA2 | 29.44 | 29.56 | 29.35 | 0.34 | 0.94 |
MUFA2 | 37.01 | 35.80 | 36.16 | 1.38 | 0.74 |
PUFA2 | 33.55 | 34.64 | 34.50 | 0.02 | 0.72 |
n-6 PUFA | 30.60 | 31.52 | 31.29 | 1.21 | 0.78 |
n-3 PUFA | 2.95 | 3.12 | 3.21 | 0.16 | 0.30 |
n-6/n-3 PUFA2 | 10.37a | 10.15a,b | 9.78b | 0.15 | 0.02 |
P/S2 | 1.14 | 1.17 | 1.17 | 0.05 | 0.75 |
a,bDifferent superscripts within a row indicate a significant difference (P < 0.05).
CTL: control; CTC: chlortetracycline; FSE: Forsythia suspensa extract.
SFA: saturated fatty acid; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acid; P/S= PUFA/SFA; n-6/n-3 PUFA = n-6 PUFA/n-3 PUFA.